» Articles » PMID: 35741404

Identification and Characterization of a New Microalga -HI from the Himalayan Region As a Potential Source of Natural Astaxanthin

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2022 Jun 24
PMID 35741404
Authors
Affiliations
Soon will be listed here.
Abstract

Synthesized astaxanthin (ASX), stereoisomers of 3S,3'R, 3R,3'R, and 3S,3'S, have over 95% market share and have relatively poor antioxidant and bioactivity properties, with persistent issues in terms of biological functions, health benefits, and biosafety if compared to natural ASX. Bioprospecting of new microalgal strains could be vital for a new source of powerful antioxidant (ASX). In this study, a new algal strain was isolated from the Indian foothills of the Himalayas. Its identity was discerned by morphological and DNA barcode studies. It is a unicellular spheroidal cell-shaped alga with 100-200 μm diameter. The isolate has 93.4% similarity to species based on 18S-rDNA phylogenetic analysis and named as -HI (HI stands for Himalayan India). Its growth and major cellular components (carotenoids, carbohydrates, protein, lipids, fatty acid profile, and ASX) were optimized using the seven different culture media. The highest biomass (1.14 g L) was observed in the MBBM medium, with a specific growth rate (0.087 day), division/day (0.125), and cellular yield (6.16 x 10 cells/mL). The highest carotenoids (1.56 mg g), lipids (32.5 mg L), and carbohydrates (135.62 mg L) were recorded in the 3N-BBM medium. The maximum ω3-FAs (17.78%), ω6-FAs (23.11%), and ω9-FAs (7.06%) were observed in MBBM, JW, and BG-11 medium respectively. The highest amount of antioxidant ASX was accumulated in the 3N-BBM medium (391 mg L). It is more than any other known algal species used in the production of natural ASX. The optimized biochemical studies on the -HI strain should fulfill the increasing demand for natural ASX for commercial application.

Citing Articles

Effects of Culture Medium Enrichment with Zinc on Astaxanthin Accumulation in a New Strain of the Microalga .

Zan Z, Huang X, Hussain Z, Zhong M, Hou C, Ren M Plants (Basel). 2024; 13(23).

PMID: 39683131 PMC: 11644740. DOI: 10.3390/plants13233338.


Study on Newly Isolated Strains from Reunion Island as Potential Sources of High-Value Carotenoids.

Jannel S, Caro Y, Bermudes M, Petit T Foods. 2024; 13(23).

PMID: 39682994 PMC: 11641088. DOI: 10.3390/foods13233922.


Astaxanthin: Past, Present, and Future.

Nishida Y, Berg P, Shakersain B, Hecht K, Takikawa A, Tao R Mar Drugs. 2023; 21(10).

PMID: 37888449 PMC: 10608541. DOI: 10.3390/md21100514.

References
1.
Brotosudarmo T, Limantara L, Setiyono E, Heriyanto . Structures of Astaxanthin and Their Consequences for Therapeutic Application. Int J Food Sci. 2020; 2020:2156582. PMC: 7391096. DOI: 10.1155/2020/2156582. View

2.
Spolaore P, Joannis-Cassan C, Duran E, Isambert A . Commercial applications of microalgae. J Biosci Bioeng. 2006; 101(2):87-96. DOI: 10.1263/jbb.101.87. View

3.
Oslan S, Shoparwe N, Yusoff A, Rahim A, Chang C, Tan J . A Review on Bioprocess Optimization of Green and Red Stage Culture Conditions for the Production of Natural Astaxanthin. Biomolecules. 2021; 11(2). PMC: 7916564. DOI: 10.3390/biom11020256. View

4.
Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H . Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod. 2006; 69(3):443-9. DOI: 10.1021/np050354+. View

5.
Regnier P, Bastias J, Rodriguez-Ruiz V, Caballero-Casero N, Caballo C, Sicilia D . Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity. Mar Drugs. 2015; 13(5):2857-74. PMC: 4446609. DOI: 10.3390/md13052857. View